A study of morbidity and drug utilization pattern in indoor patients of high risk pregnancy at tertiary care hospital
Keywords:
Drug utilization, High risk pregnancy, WHO core drug prescribing indicatorsAbstract
Background: Pregnancy represents a special physiological state during which the use of drug is of growing concern due to risk of teratogenicity. High risk pregnancy is common threat to mother and foetus. Therefore, our aim was to study the drug utilization and morbidity pattern in high risk pregnancy in hospitalized pregnant women.
Methods:An observational, prospective study was carried out in 250 patients for 6 months in the tertiary care hospital. Protocol was approved by the Institutional Review Board (IRB). The data were collected in a pre-designed proforma. Data were analysed by using SPSS version 20.0 Software.
Results: Among 250 patients, 19 (7.6%), 218 (87.2%) and 13 (5.2%) were of less than 20, 20 to 30 and more than 30 years of age respectively. About 68.8% women had complained of abdominal pain and 67.6% had weakness followed by headache / body ache (47.2%), oedema (26.4%) and vomiting (18.8%). Iron (91.2%) and calcium (84.5%) were the commonest drugs prescribed followed by folic acid (59.6%), protein powder (54.8%), vitamin C (46.8%) and isoxsuprine (26.6%). As per FDA Drug Risk Category, Category-A (82.21%) was most frequently prescribed followed by Category-B (15.64%) and Category-C (2.15%). Percentage of drugs prescribed by generic name and from essential drug list was 62.80% and 80.79%.
Conclusion: Iron, Calcium and Folic acid were most commonly prescribed drugs. There is lesser number of drugs prescribed by generic name suggesting need for sincere efforts to improve situation.
Metrics
References
Nordeng H, Eskild A. Nesheim BI, Jacobsen G. Drug use in pregnancy among parous scandinavian women. N J Epidem 2001; 11: 97-103.
Beers, Mark H. "High-Risk Pregnancies." In The Merck Manual of Diagnosis and Therapy. Rahway, NJ: Merck Research Laboratories, 2004.
Frankos VH. FDA Perspectives on the use of teratology data for human risk. Assessment Fundam Appl Toxicol 1985;5:615-25.
World Health Organization. How to investigate drug use in health facilities, selected drug use indicators, WHO/DAP/93.1. Geneva: World health Organization, 1993, P:10.
Smith JB, Lakhey B, Thapa S, Rajbhandari S, Neupane S Maternal morbidity among women admitted for delivery at a public hospital in Kathmandu. JNMA J Nepal Med Assoc. 1996; 34(118-119):132-40.
Tim Badgery-Parker, Jane B Ford, Mary G Jenkins, Jonathan M Morris and Christine L Roberts Patterns and outcomes of preterm hospital admissions during pregnancy in NSW, 2001–2008. Med J Aust 2012; 196 (4): 261-265.
Hernandez - Diaz S, Werler MM, Louik C. Risk of gestational hypertension in relation to folic-acid supplementation during pregnancy. Am J Epidemiol 2002; 156: 806-12.
Fauzia Akhter Huda, Anisuddin Ahmed, Sushil Kanta Dasgupta, Musharrat Jahan. Profile of Maternal and Foetal Complications duringLabour and Delivery among Women Giving Birth in Hospitals in Matlab and Chandpur, Bangladesh. J Health Popul Nutr 2012 Jun;30(2):131-142.
Evers AC, Brouwers HA, Hukkelhoven CW, Nikkels PG, Boon J, van Egmond-Linden A, Hillegersberg J, Snuif YS, Sterken-Hooisma S, Bruinse HW, Kwee A. Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study. BMJ. 2010 Nov 2;341.
Bondevik GT, Lie RT, Ulstein M, Kvale G. Maternal hematological status and risk of low birth weight and preterm delivery in Nepal. Acta Obstet Gynaecol Scand 2001; 80:402-8.
Abel R, Rajaratnam J, Gnanasekarana VJ, Jayaraman P. Prevalence of anemia and iron deficiency in three trimesters in Rural Vellare District, South India. Trop Doct 2001; 31: 86-9.
Milman N, Bergholt T, Byg KE, Eriksen L, Graudal N. Iron status and iron balance during pregnancy. A critical re-appraisal of iron supplementation. Acta Obstet Gynaecol Scand 1999; 78: 749-57.
Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Eng J Med 1992; 327:1832-5.
Shu EN, Ogbodo SO. Role of ascorbic acid in the prevention of iron-deficiency anaemia in pregnancy. Biomedical Research. 2005;16(1):40-44.
Ohnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr. 1993 Jul;58(1):103-5.
Mah-e-Munir Awan, Muhammad Aftab Akbar, . Misbahul Islam Khan, A study of anemia in pregnant women of railway colony, Multan. Pakistan J Med Res 2004;43:240-5.
Ahmed F. Anemia in Bangladesh: a review of prevalence and etiology of anemia. Public Health Nutr 2000; 3: 385-93.
Kiwanuka GN, Isharaza WK, Mahmoud S. Iron status of pregnant women at first antenatal booking in Mbara University Teaching Hospital. Trop Doct 2000; 29: 228-30.
Cogswell ME, Kettel-Khan L, Ramakrishnan U. Iron supplement use among women in the United States: science, policy and practice. J Nutr. 2003 Jun; 133(6):1974-1977.
Hess SY, Zimmermann MB, Brogli S, Hurrell RF. A national survey of iron and folate status in pregnant women in Switzerland. Int J Vitam Nutr Res. 2001 Sep; 71(5):268-273.
Das B, Sarkar C, Datta A, Bohra S. A study of drug use during pregnancy in a teaching hospital in western Nepal. Pharmacoepidemiol Drug Saf. 2003 Apr-May; 12(3):221-225.
Rizk MA, Abdel-Aziz F, Ashmawy AA, Mahmoud AA, Abuzeid TM. Knowledge and practices of pregnant women in relation to the intake of drugs during pregnancy. J Egypt Public Health Assoc. 1993; 68(5-6):567-591.
Moradi, S. Mohammadi, A. A. Kadiva and S. J. Masoumi. Knowledge and practice of pregnant women in fars province about intake of iron supplements. Acta Medica Iranica 2007;45:299-304.
MK Omole, AI Akanji Pharmacotherapy of Hypertension in pregnancy in a Secondary Hospital in South West Nigeria. Nigerian Journal of Pharmaceutical Research 2003;8:1-11.
Aal DE, Shahin AY, Management of eclampsia at Assiut University Hospital, Egypt. Int J Gynaecol Obstet. 2012 Mar;116(3):232-6.
Jangra Sarita, Bhyan Bhupinder Evaluation of Antihypertensive Therapy of Pregnancy Induced Hypertensive Patients in Mahila Chiktsalaya, Jaipur. JPSBR 2012;2:5-10.
Malhotra B, Deka D. Duration of the increase in amniotic fluid index (AFI) after acute maternal hydration. Arch Gynecol Obstet. 2004 Mar; 269 (3): 173-5.
Tchirikov M, Kharkevich O, Steetskamp J, Beluga M, Strohner M. Treatment of Growth - Restricted Human Fetuses with Amino Acids and Glucose Supplementation through a Chronic Fetal Intravascular Perinatal Port System. Eur Surg Res. 2010 Aug 20;45(1):45-49.
Gilson G, Murphy N. Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska Native women. Am J Obstet Gynecol 2002;167:187-90.
Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med 2004;15:51-5.
Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, De Jong - Van Den Berg LT. Drug prescription pattern before during and after pregnancy for chronic, occasional and pregnancy related drugs in the Netherlands. Br J Obstet Gynecol 2006;113:559-68.
Andrade SE, Gurwitz JH, Davis RL, Chan KA et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004;191:398-407.
Malm H, Martikainen J, Kalukka T, Neuvonen PJ. Prescription of hazardous during pregnancy. Drug Saf 2004;27:899-908.
Tisonova J, Magulova L, Goboova M, et al. Consultation activity of two Slovak Centres for pharmacotherapy during pregnancy and lactation. Cas Lek Lesk 2006;145:154-9.
